It truly is concluded that EAM-2201 has the possible to cause in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, which is evaluated in pooled human liver microsomes. Notes: This potential was made for reports of MAX period deformation, with distinct notice paid to replicating the traits o